Clark Eliana

CIK 00019144481 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001914448

Recent Transactions

25 trades

Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−9,515→ 87,118 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-07-01$9.82/sh−1,022→ 95,369 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-04$8.99/sh−679→ 95,369 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-03-01+45,714→ 45,714 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+32,000→ 96,048 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-03$12.18/sh−7,422→ 64,048 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-02$12.03/sh−556→ 71,470 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-07-01$22.93/sh−405→ 71,470 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-04$32.99/sh−605→ 71,470 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-01+31,230→ 72,075 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-03-01+45,072→ 45,072 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$29.46/sh−4,301→ 40,845 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$30.12/sh−307→ 45,146 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-07-03$40.51/sh−360→ 45,146 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-20$12.27/sh+5,000→ 50,146 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-06-20−5,000→ 57,750 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-20$45.00/sh−5,000→ 45,146 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+24,539→ 39,012 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+6,134→ 45,146 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-03-01+34,674→ 34,674 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-04$37.21/sh−1,692→ 14,473 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-03$34.48/sh−231→ 16,165 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-07-01$51.74/sh−105→ 16,165 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+15,395→ 15,395 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-03-01+10,527→ 16,165 total

Companies

Intellia Therapeutics, Inc.
EVP, Chief Technical Officer
$NTLA

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov